ASCO has measures that have been fully developed and are not yet NQF-endorsed or implemented in a program. ASCO measures are copyrighted, and commercial uses of the measures require a license agreement between the user and ASCO.  Commercial use is defined as the sale, license, or distribution of the measures for commercial gain, or incorporation of the measure into a product or service that is sold, licensed, or distributed for commercial gain.  If your organization is interested in licensing ASCO measures, please contact measurement@asco.org.

Measure Title

Year Developed

Appropriate Antiemetic Therapy for Moderate-Emetic-Risk Antineoplastic Agents

2019

Antiemetic Therapy for Low- and Minimal-Emetic-Risk Antineoplastic Agents – Avoidance of Overuse (Lower Score – Better)

2019

Moderate Hypofractionation for Prostate Cancer

2019

Hypofractionated Whole Breast Irradiation

2019

BRAF Molecular Screening During Workup for Advanced Melanoma

2019

Screening for Brain Metastases at Initial Diagnosis of Advanced Melanoma

2019